Feasibility and safety of Laparoscopic Complete Mesocolic Ex
Laparoscopic complete mesocolic excision (CME) is a feasible and safe treatment option for right-sided colon cancer, finds a study published in the Annals of Surgery.

The aim of this prospective clinical study is to compare the short-term outcome of laparoscopic right hemicolectomy using the Complete Mesocolic Excision (CME group) with patients who underwent conventional right-sided colonic resection (NCME group).

In this randomized controlled trial, several primary endpoints (operative time, intraoperative blood loss, other complications, conversion rate, and anastomotic leak) and secondary endpoints (overall postoperative complications) were evaluated. In addition, they evaluated histopathologic data, including specimen length and the number of lymph nodes harvested, as objective signs of the quality of CME, related to oncological outcomes.

- The CME group had a significantly longer mean operative time than the NCME group.

- However, the CME group had a higher number of lymph nodes and larger surgical specimens.

- No differences were reported with respect to intraoperative blood loss, conversion rate, leakage, or other postoperative complications.

Conclusively, in this study laparoscopic CME was a safe and feasible technique with improvement in lymph nodes harvesting and length of surgical specimens with no increase of surgical intraoperative and postoperative complications.

Source: https://journals.lww.com/annalsofsurgery/Abstract/2021/07000/Feasibility_and_Safety_of_Laparoscopic_Complete.15.aspx